Market Highlights

Vitiligo is a skin condition characterized by white patches on the skin. The patches are a result of the loss of melanocytes. The global vitiligo treatment market report by Market Research Future (MRFR) contains useful drivers, challenges, and insights till forecast period. The effects of the COVID-19 pandemic on the production of skin pigmentation drugs and other medicines have been included in the report with a special emphasis on each region.

According to MRFR analysis, Vitiligo Treatment Market Growth is expected to cross USD 1.84 Billion at a CAGR of 5.6%.

Huge prevalence of vitiligo is one of the primary drivers of the market. This is exemplified by the treatment of close to 150,000 Americans in the U.S. Investments in healthcare infrastructure by developing and developed economies can influence the market. Changes in lifestyles and awareness of the skin condition among the populace can bode well for the market. Development of new therapies and treatment and focus on external appearances will fuel treatment demand. For instance, researchers at the University of Massachusetts Medical School have developed a targeted therapy which can remove the cells responsible for causing vitiligo. The approval of this treatment can revolutionize the industry.

But lack of trained professionals, product recalls, and strict regulations on treatment manufacturers can create a bottleneck for the market growth.

Segmentation

The global vitiligo treatment market is segmented by type, treatment type, and end user.

By type, it is divided into segmental vitiligo and nonsegmental vitiligo. The nonsegmental vitiligo is expected to dominate the market till 2025.

By treatment type, it is segmented into surgery, medication, and therapy. The medication segment is projected to drive the market growth over the forecast period due to approval of the latest drugs by federal regulation bodies. Low cost of treatment compared to others is one of the biggest growth drivers of the segment.

By end user, it is segmented into aesthetic clinics, hospitals & clinics, and others. Hospitals & clinics are expected to dominate the market during the forecast period. This can be attributed to the preference of these healthcare facilities by patients as the primary point of care.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8442

Key Players

• Novartis AG (Basel, Basel-Stadt)
• Allergan, Inc. (Dublin, Coolock)
• Clinuvel Pharmaceuticals Limited (Melbourne, Victoria)
• Astellas Pharma Inc. (Northbrook, IL)
• Bausch Health Companies Inc. (Laval, Quebec)
• STRATA Skin Sciences (Horsham, PA)
• Reddys Laboratories Ltd. (India)
• Eli Lilly Company (Indianapolis, Indiana)
• Incyte Corporation (Wilmington, Delaware)
• AstraZeneca AB (Cambridge, Cambridgeshire)
• Epizyme, Inc. (Cambridge, MA)
• Baxter International Inc. (Deerfield, Illinois)
• Pfizer Inc. (New York)

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to be the largest market owing to the significant investments by healthcare and medical regulatory bodies in vitiligo treatment to deliver quick medical aid to patients. The vitiligo treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European vitiligo treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The vitiligo treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing number of patients with vitiligo and increasing mergers & acquisitions among the market players are boosting the Asia-Pacific region. The vitiligo treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/vitiligo-treatment-market-8442

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com